Literature DB >> 20138323

Unacceptable attrition among WHO stages 1 and 2 patients in a hospital-based setting in rural Malawi: can we retain such patients within the general health system?

Katie Tayler-Smith1, Rony Zachariah, Moses Massaquoi, Marcel Manzi, Olesi Pasulani, Thomas van den Akker, Marielle Bemelmans, Ariane Bauernfeind, Beatrice Mwagomba, Anthony D Harries.   

Abstract

A study conducted among HIV-positive adults in WHO clinical stages 1 and 2 was followed up at Thyolo District Hospital (rural Malawi) to report on: (1) retention and attrition before and while on antiretroviral treatment (ART); and (2) the criteria used for initiating ART. Between June 2008 and January 2009, 1633 adults in WHO stages 1 and 2 were followed up for a total of 282 person-years. Retention in care at 1, 2, 3 and 6 months for those not on ART (n=1078) was 25, 18, 11 and 4% vs. 99, 97, 95 and 90% for patients who started ART (n=555, P=0.001). Attrition rates were 31 times higher among patients not started on ART compared with those started on ART (adjusted hazard ratio, 31.0, 95% CI 22-44). Ninety-two patients in WHO stage 1 or 2 were started on ART without the guidance of a CD4 count, and 11 were incorrectly started on ART with CD4 count > or = 250 cells/mm(3). In a rural district hospital setting in Malawi, attrition of individuals in WHO stages 1 and 2 is unacceptably high, and specific operational strategies need to be considered to retain such patients in the health system. Copyright 2010 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20138323     DOI: 10.1016/j.trstmh.2010.01.007

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  36 in total

Review 1.  Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis.

Authors:  Amitabh B Suthar; Reuben Granich; Jonathan Mermin; Annelies Van Rie
Journal:  Bull World Health Organ       Date:  2011-10-24       Impact factor: 9.408

2.  Impact of Patient-Selected Care Buddies on Adherence to HIV Care, Disease Progression, and Conduct of Daily Life Among Pre-antiretroviral HIV-Infected Patients in Rakai, Uganda: A Randomized Controlled Trial.

Authors:  Gertrude Nakigozi; Fredrick E Makumbi; John B Bwanika; Lynn Atuyambe; Steven J Reynolds; Godfrey Kigozi; Fred Nalugoda; Larry W Chang; Valerian Kiggundu; David Serwadda; Maria J Wawer; Ronald H Gray; Moses R Kamya
Journal:  J Acquir Immune Defic Syndr       Date:  2015-09-01       Impact factor: 3.731

3.  Implementation of free cotrimoxazole prophylaxis improves clinic retention among antiretroviral therapy-ineligible clients in Kenya.

Authors:  Pamela K Kohler; Michael H Chung; Christine J McGrath; Sarah F Benki-Nugent; Joan W Thiga; Grace C John-Stewart
Journal:  AIDS       Date:  2011-08-24       Impact factor: 4.177

4.  Use of a Comprehensive HIV Care Cascade for Evaluating HIV Program Performance: Findings From 4 Sub-Saharan African Countries.

Authors:  Margaret L McNairy; Matthew R Lamb; Elaine J Abrams; Batya Elul; Ruben Sahabo; Mark P Hawken; Antonio Mussa; Ayele Zwede; Jessica Justman; Wafaa M El-Sadr
Journal:  J Acquir Immune Defic Syndr       Date:  2015-10-01       Impact factor: 3.731

Review 5.  Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis.

Authors:  Catrina Mugglin; Janne Estill; Gilles Wandeler; Nicole Bender; Matthias Egger; Thomas Gsponer; Olivia Keiser
Journal:  Trop Med Int Health       Date:  2012-09-20       Impact factor: 2.622

Review 6.  Cascade of Refusal-What Does It Mean for the Future of Treatment as Prevention in Sub-Saharan Africa?

Authors:  Ingrid T Katz; David R Bangsberg
Journal:  Curr HIV/AIDS Rep       Date:  2016-04       Impact factor: 5.071

7.  Attrition from HIV testing to antiretroviral therapy initiation among patients newly diagnosed with HIV in Haiti.

Authors:  Edva Noel; Morgan Esperance; Megan McLaughlin; Rachel Bertrand; Jessy Devieux; Patrice Severe; Diessy Decome; Adias Marcelin; Janet Nicotera; Chris Delcher; Mark Griswold; Genevive Meredith; Jean William Pape; Serena P Koenig
Journal:  J Acquir Immune Defic Syndr       Date:  2013-03-01       Impact factor: 3.731

8.  Failure to initiate antiretroviral therapy, loss to follow-up and mortality among HIV-infected patients during the pre-ART period in Uganda.

Authors:  Elvin H Geng; Mwebesa B Bwana; Winnie Muyindike; David V Glidden; David R Bangsberg; Torsten B Neilands; Ingrid Bernheimer; Nicolas Musinguzi; Constantin T Yiannoutsos; Jeffrey N Martin
Journal:  J Acquir Immune Defic Syndr       Date:  2013-06-01       Impact factor: 3.731

9.  Consideration of postpartum management in HIV-positive Haitian women: an analysis of CD4 decline, mortality, and follow-up after delivery.

Authors:  Alexandra Coria; Francine Noel; Jerry Bonhomme; Vanessa Rouzier; Christian Perodin; Adias Marcelin; Zhongze Li; Tor D Tosteson; Marie-Marcelle Deschamps; Peter F Wright; Jean W Pape
Journal:  J Acquir Immune Defic Syndr       Date:  2012-12-15       Impact factor: 3.731

10.  What happens to ART-eligible patients who do not start ART? Dropout between screening and ART initiation: a cohort study in Karonga, Malawi.

Authors:  Nuala McGrath; Judith R Glynn; Jacqueline Saul; Katharina Kranzer; Andreas Jahn; Frank Mwaungulu; Msenga H C Ngwira; Hazzie Mvula; Fipson Munthali; Venance Mwinuka; Lorren Mwaungulu; Paul E M Fine; Amelia C Crampin
Journal:  BMC Public Health       Date:  2010-10-12       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.